- Home
- HMC vs TAK Comparison
HMC vs TAK Comparison
Compare HMC & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMC | TAK |
|---|---|---|
| Founded | 1946 | 1781 |
| Country | Japan | Japan |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2B | 43.3B |
| IPO Year | 1957 | N/A |
Fundamental Metrics
Financial Performance| Metric | HMC | TAK |
|---|---|---|
| Price | $29.78 | $16.38 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 02-12-2026 | 01-29-2026 |
| Dividend Yield | ★ 3.65% | 3.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.02 | 0.14 |
| Revenue | ★ $145,442,121,011.00 | $29,846,840,032.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.38 | $0.47 |
| P/E Ratio | ★ $28.65 | $114.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.56 | $12.80 |
| 52 Week High | $34.89 | $15.98 |
Technical Indicators
Market Signals| Indicator | HMC | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 83.18 |
| Support Level | $29.47 | $15.48 |
| Resistance Level | $30.13 | $15.78 |
| Average True Range (ATR) | 0.24 | 0.19 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 50.13 | 99.99 |
Price Performance
Historical ComparisonAbout HMC Honda Motor Company Ltd.
Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.7 million light vehicles and 20.6 million motorcycles in fiscal 2025, and consolidated sales were JPY 21.7 trillion. Automobiles constitute 65% of revenue and motorcycles 17%, with the rest split between power products and financial services. Honda also makes robots and private jets.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.